HHS to move forward with long-delayed 340B ceiling price rule

Modern Healthcare: HHS wants to cancel its plans to postpone imposing new ceiling prices for the 340B drug discount program.

The agency issued a proposed rulemaking on Wednesday that suggested the long-delayed rule will now be effective Jan. 1, instead of July 1, 2019, as originally announced earlier this year.

HHS has delayed the effective date of the ceiling price rule five times, which would cap the prices drugmakers can charge hospitals that participate in 340B. The American Hospital Association and several other medical trade groups sued the agency last fall to force it to publish the delayed regulations.

Read article